NCT03948854

Brief Summary

Researchers are trying to determine the best course of action regarding the dietary management with a diet low in fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP diet) for irritable bowel syndrome.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
49

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 10, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 14, 2019

Completed
8 days until next milestone

Study Start

First participant enrolled

May 22, 2019

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 19, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 19, 2022

Completed
Last Updated

December 14, 2022

Status Verified

December 1, 2022

Enrollment Period

2.8 years

First QC Date

May 10, 2019

Last Update Submit

December 12, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Improvement in IBS symptoms

    Change in IBS symptoms will be measured from baseline to the end of study using the validated IBS symptoms severity scale (IBS-SS). This is a visual analog scale from 0-100. The primary outcome measure is improvement in symptom scores from end of study to baseline.

    Baseline, end of study approximately 8 to 10 weeks

Study Arms (4)

Registered dietitian education

EXPERIMENTAL

Subjects with irritable bowel syndrome (IBS) will receive education on FODMAP diet in person by a registered dietitian

Other: Registered dietitian

On-line video program education

EXPERIMENTAL

Subjects with irritable bowel syndrome (IBS) will receive education on FODMAP diet using an on-line video program

Other: On-line video program

Handout education

EXPERIMENTAL

Subjects with irritable bowel syndrome (IBS) will receive education on FODMAP diet by a printed handout

Other: Printed handout

Dietitian-led group education

EXPERIMENTAL

Subjects with irritable bowel syndrome (IBS) will receive education on FODMAP diet in a dietitian-led group setting

Other: Dietitian-led group

Interventions

Education on low FODMAP diet is provided in person by a registered dietitian who is an expert on the low FODMAP diet

Registered dietitian education

Education on low FODMAP diet is provided by an on-line program via a link sent through email

On-line video program education

Education on low FODMAP diet is provided through printed handout material at the initial visit.

Handout education

Education on low FODMAP diet is provided in a dietitian-led group setting

Dietitian-led group education

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult subjects (18-75 years) seen in the primary care clinic or in the Gastroenterology clinic at Mayo Clinic Florida, who are diagnosed with IBS by Rome IV criteria

You may not qualify if:

  • Subjects who have previously tried the low FODMAP diet (whether successful or not)
  • Current or recent (less than 4 weeks) opioid use
  • Current or recent (less than 10 weeks) rifaximin use
  • Inability to speak or read English
  • Pregnancy and/or breast-feeding
  • Medical or psychological issues that would prevent modifying their diet for 8 weeks.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic in Florida

Jacksonville, Florida, 32224, United States

Location

Related Links

MeSH Terms

Conditions

Irritable Bowel Syndrome

Condition Hierarchy (Ancestors)

Colonic Diseases, FunctionalColonic DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System Diseases

Study Officials

  • Brian Lacy, MD

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 10, 2019

First Posted

May 14, 2019

Study Start

May 22, 2019

Primary Completion

February 19, 2022

Study Completion

February 19, 2022

Last Updated

December 14, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations